PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
CureGene Completes First‑Participant Dose in Phase I Trial of CG‑0416, Advancing Clinical Development of Novel Oral Liver-Targeting THR-β Agonist
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
China's Personalized mRNA Cancer Therapy Sector Accelerates: How Far Is It From a "DeepSeek Moment"?
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) NDA Accepted by NMPA, Poised to Become World's First Approved 4-1BB-Targeting Therapy
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Dizal to Present Emerging Data on ZEGFROVY® in Non-Small Cell Lung Cancer at WCLC 2026
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
/C O R R E C T I O N -- Akeso, Inc./
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Sunshine Guojian Releases 2026 Interim Report:
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Angel Yeast's AHH Packaging Design Recognized with Red Dot Award
2026-08-21T    Biotechnology   Food/Beverages   Health Care/Hospital 
Matwings Demonstrates Closed-Loop Protein AI Through Four AI-Wet Lab Cycles and 222 Protein Variants
2026-08-20T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved